CBS-2402

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameCBS-2402
Drug Alias Namearyl benzoate derivatives (CanBas)CBDC-402CBS-2402
ClassificationSmall molecules
Mechanisms of ActionCheckpoint kinase inhibitorsAnticancer protein kinase inhibitors
TargetsCheckpoint kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCanbas Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCanbas Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A